The emerging approach of this peptide represents a significant breakthrough in the management of the condition. Unlike existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide985429.csublogs.com/50028948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment